Norge -
norsk -
Statens legemiddelverk
otrason 50 mikrog/ dose
haleon denmark aps - flutikasonpropionat - nesespray, suspensjon - 50 mikrog/ dose
Den europeiske union -
norsk -
EMA (European Medicines Agency)
erivedge
roche registration gmbh - vismodegib - karsinom, basalcelle - antineoplastiske midler - erivedge er indisert for behandling av voksne pasienter med:- symptomatisk metastatisk basal cell carcinoma - lokalt avansert basal cell carcinoma uegnet for kirurgi eller strålebehandling.
Norge -
norsk -
Statens legemiddelverk
erivedge 150 mg
orifarm as - vismodegib - kapsel, hard - 150 mg
Norge -
norsk -
Statens legemiddelverk
erivedge 150 mg
2care4 aps - vismodegib - kapsel, hard - 150 mg
Norge -
norsk -
Statens legemiddelverk
erivedge 150 mg
abacus medicine a/s - vismodegib - kapsel, hard - 150 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
exalief
bial - portela ca, s.a. - eslikarbazepinacetat - epilepsi - antiepileptics, - exalief er angitt som tilleggsbehandling behandling hos voksne med delvis-utbruddet anfall med eller uten sekundær generalisering.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastiske midler - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.